📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex (2024)

First Author: Damianou A

Attributed to: Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202302245

PubMed Identifier: 38453365

Publication URI: http://europepmc.org/abstract/MED/38453365

Type: Journal Article/Review

Parent Publication: Life Science Alliance

Issue: 5

ISSN: 2575-1077